Sleep, 24-h activity rhythms, and plasma markers of neurodegenerative disease

scientific article published on 26 November 2020

Sleep, 24-h activity rhythms, and plasma markers of neurodegenerative disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-020-77830-4
P698PubMed publication ID33244083

P2093author name stringM Arfan Ikram
Mohsen Ghanbari
Annemarie I Luik
Thom S Lysen
P2860cites workThe sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humansQ69411660
Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apneaQ87886489
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysisQ88197767
The bidirectional relationship between sleep duration and depression in community-dwelling middle-aged and elderly individuals: evidence from a longitudinal studyQ88965203
Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?Q89345926
Serum neurofilament light levels in normal aging and their association with morphologic brain changesQ89636874
Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adultsQ90078937
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer DiseaseQ90139959
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort studyQ90613879
Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's diseaseQ91072650
Multidimensional Sleep and Mortality in Older Adults: A Machine-Learning Comparison With Other Risk FactorsQ91693785
Association between circadian rhythms and neurodegenerative diseasesQ91738117
Regional Gray Matter Volume Links Rest-Activity Rhythm Fragmentation With Past Cognitive DeclineQ92385329
Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young menQ92502447
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measuresQ92641125
Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human BrainQ92825260
Sleep deprivation and plasma biomarkers for Alzheimer's diseaseQ92892327
Dementia prevention, intervention, and care: 2020 report of the Lancet CommissionQ98186330
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchQ29547257
Sleep drives metabolite clearance from the adult brainQ29620065
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working GroupQ33726399
Sleep duration and cardiovascular disease: results from the National Health Interview Survey.Q34022131
Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic rangeQ34669231
Sleep, Cognitive impairment and Alzheimer's disease: A systematic review and meta-analysisQ36150290
Neurofilaments at a glanceQ36450980
Who are the long sleepers? Towards an understanding of the mortality relationship.Q36878173
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.Q37149094
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementiaQ37304614
Sleep health: can we define it? Does it matter?Q37518479
Altered sleep and EEG power in the P301S Tau transgenic mouse modelQ37681990
Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?Q38871392
Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adultsQ46061056
The Rotterdam Study: 2018 update on objectives, design and main resultsQ47121939
Sleep disturbances increase the risk of dementia: A systematic review and meta-analysisQ47625482
Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly personsQ47706414
Activity/rest cycle and disturbances of structural backbone of cerebral networks in agingQ47812984
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseQ48243501
Sleep Deprivation and CSF Biomarkers for Alzheimer DiseaseQ50051296
Intrinsic Neuronal Stress Response Pathways in Injury and DiseaseQ50135855
Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.Q52609774
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.Q54182425
Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic strokeQ57049032
Neurofilaments as biomarkers in neurological disordersQ57588817
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseQ60961744
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort studyQ61800425
Principles of confounder selectionQ64056318
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysisQ64761571
P433issue1
P304page(s)20691
P577publication date2020-11-26
P1433published inScientific ReportsQ2261792
P1476titleSleep, 24-h activity rhythms, and plasma markers of neurodegenerative disease
P478volume10

Search more.